Epigenetic regulation of normal and malignant hematopoiesis
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA methylation patterns and epigenetic memory
Bird, A. (2002) · Genes & Development · doi:10.1101/gad.947102 · Cited by 7,124 · cited 4×
“Bird A. (2002). DNA methylation patterns and epigenetic memory.”
BackgroundInfluentialThe nuclear receptor superfamily: the second decade
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964 · cited 1×
“Upon treatment with retinoic acid (RA), however, these receptors undergo a conformational change that results in the release of corepressors and binding of co-activators, thus facilitating transcription (Mangelsdorf et al., 1995).”
BackgroundHistone demethylation mediated by the nuclear amine oxidase homolog LSD1
Shi, Y., Lan, F., Matson, C., Mulligan, P., Whetstine, J. R., Cole, P. A., Casero, R. A., & Shi, Y. (2004) · Cell · doi:10.1016/j.cell.2004.12.012 · Cited by 4,051
Regulation of chromatin structure by site-specific histone H3 methyltransferases
Rea, S., Eisenhaber, F., O'Carroll, D., Strahl, B. D., Sun, Z.-W., Schmid, M., Opravil, S., Mechtler, K., Ponting, C. P., Allis, C. D., et al. (2000) · Nature · doi:10.1038/35020506 · Cited by 2,845 · cited 7×
“, 2002) and human (Rea et al., 2000) have HMT activity that maps to the SET domain and in some of these proteins, cysteine–rich sequences flanking the domain were also required for methyltransferase activity.”
BackgroundInfluentialBernstein, B. E., Meissner, A., & Lander, E. S. (2007) · Cell · doi:10.1016/j.cell.2007.01.033 · Cited by 2,086 · cited 2×
“…ChIP and genomic tiling arrays, high-performance capillary electrophoresis and liquid chromatography–electrospray mass spectrometry, has provided intriguing insights into the structure of the epigenome that characterizes normal and malignant cells (Fraga and Esteller, 2005; Bernstein et al., 2007).”
BackgroundMethylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene
Bell, A. C., & Felsenfeld, G. (2000) · Nature · doi:10.1038/35013100 · Cited by 1,746 · cited 1×
“Specifically, methylation of CpG dinucleotides on the paternal allele blocks binding of CTCF and allows a downstream enhancer to activate Igf2 expression via a looping mechanism (Bell and Felsenfeld, 2000; Yoon et al., 2007).”
BackgroundA novel class of small RNAs bind to MILI protein in mouse testes
Aravin, A., Gaidatzis, D., Pfeffer, S., Lagos-Quintana, M., Landgraf, P., Iovino, N., Morris, P., Brownstein, M. J., Kuramochi-Miyagawa, S., Nakano, T., et al. (2006) · Nature · doi:10.1038/nature04916 · Cited by 1,516 · cited 1×
“The recent finding that Piwi, an Argonaute protein that has been shown to associate with a new class of small RNAs known as piRNAs (Aravin et al., 2006), interacts with HP1 suggests that these piRNAs may also play a role in heterochromatin formation (Ambros and Chen, 2007).”
BackgroundBmi-1 determines the proliferative capacity of normal and leukaemic stem cells.
Lessard, J., & Sauvageau, G. (2003) · Nature · doi:10.1038/nature01572 · Cited by 1,452 · cited 1×
“Given its critical role in normal stem cell function, it seems likely that BMI1 plays an important role in the ability of the cancer cell to undergo limitless self-renewal (Lessard and Sauvageau, 2003).”
BackgroundOncogene-induced senescence as an initial barrier in lymphoma development
Braig, M., Lee, S., Loddenkemper, C., Rudolph, C., Peters, A. H. F. M., Schlegelberger, B., Stein, H., Dörken, B., Jenuwein, T., & Schmitt, C. A. (2005) · Nature · doi:10.1038/nature03841 · Cited by 1,220
Zhang, Y., Ng, H.-H., Erdjument-Bromage, H., Tempst, P., Bird, A., & Reinberg, D. (1999) · Genes & Development · doi:10.1101/gad.13.15.1924 · Cited by 1,103 · cited 2×
“, 2003); and the NuRD multifunctional repression complex (Zhang et al., 1999).”
BackgroundGlinsky, G. V., Berezovska, O., & Glinskii, A. B. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23412 · Cited by 916 · cited 2×
“Similarly, dysregulation of BMI1 also affects the activity of the PRCs, and overexpression and overactivity of BMI1 has been associated with a variety of solid tumors including lung, breast, colon, prostate and neuroblastoma as well as in malignant hematopoiesis (Breuer et al., 2004; Glinsky et al., 2005; Steele et al…”
BackgroundTan, J., Yang, X., Zhuang, L., Jiang, X., Chen, W., Lee, P. L., Karuturi, R. K. M., Tan, P. B. O., Liu, E. T., & Yu, Q. (2007) · Genes & Development · doi:10.1101/gad.1524107 · Cited by 895 · cited 1×
“Treatment of breast cancer cells with DZNep resulted in the reactivation of a number of genes Oncogene repressed by PRC2 and induced apoptosis in cancer cells but not in normal cells (Tan et al., 2007).”
BackgroundReversal of H3K9me2 by a Small-Molecule Inhibitor for the G9a Histone Methyltransferase
Kubicek, S., O'Sullivan, R. J., August, E. M., Hickey, E. R., Zhang, Q., Teodoro, M. L., Rea, S., Mechtler, K., Kowalski, J. A., Homon, C. A., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.01.017 · Cited by 859
Regulation of activity of the transcription factor GATA-1 by acetylation
Boyes, J., Byfield, P., Nakatani, Y., & Ogryzko, V. (1998) · Nature · doi:10.1038/25166 · Cited by 694 · cited 1×
“GATA-1 itself is also acetylated on conserved lysine residues by CBP, and although the effect of this modification remains controversial, the net result is enhanced transcriptional activity (Boyes et al., 1998; Hung et al., 1999).”
BackgroundHoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b
Kroon, E., Krosl, J., Thorsteinsdottir, U., Baban, S., Buchberg, A. M., & Sauvageau, G. (1998) · The EMBO Journal · doi:10.1093/emboj/17.13.3714 · Cited by 640
Hung, H.-L., Lau, J., Kim, A. Y., Weiss, M. J., & Blobel, G. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3496 · Cited by 247 · cited 1×
“GATA-1 itself is also acetylated on conserved lysine residues by CBP, and although the effect of this modification remains controversial, the net result is enhanced transcriptional activity (Boyes et al., 1998; Hung et al., 1999).”
BackgroundRosenbauer, F., Owens, B. M., Yu, L., Tumang, J. R., Steidl, U., Kutok, J. L., Clayton, L. K., Wagner, K., Scheller, M., Iwasaki, H., et al. (2006) · Nature Genetics · doi:10.1038/ng1679 · Cited by 237 · cited 12×
“NSD3 is located in a genomic region amplified in breast cancer (Angrand et al., 2001) and is also fused to NUP98 in AML associated with the t(8;11) translocation (Rosati et al., 2002). hDOT1L is an HMTase that lacks the SET domain and specifically methylates H3K79, a residue located within the globular domain of histo…”
BackgroundInfluentialSteele-Perkins, G., Fang, W., Yang, X.-H., Van Gele, M., Carling, T., Gu, J., Buyse, I. M., Fletcher, J. A., Liu, J., Bronson, R., et al. (2001) · Genes & Development · doi:10.1101/gad.870101 · Cited by 208 · cited 1×
“RIZ1 knockout mice develop B-cell lymphoma (Steele-Perkins et al., 2001), and in chronic myelogenous leukemia (CML), blastic transformation is associated with loss of heterozygosity in the vicinity of RIZ1 and a decrease in RIZ1 expression (Pastural et al., 2007).”
BackgroundGenome-Wide Analysis of KAP1 Binding Suggests Autoregulation of KRAB-ZNFs
O'Geen, H., Squazzo, S. L., Iyengar, S., Blahnik, K., Rinn, J. L., Chang, H. Y., Green, R., & Farnham, P. J. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030089 · Cited by 178 · cited 1×
“These studies now allow the identification of canonical and novel binding motifs within promoter, enhancer and transcribed regions of target genes (O’Geen et al., 2007).”
BackgroundStopka, T., Amanatullah, D. F., Papetti, M., & Skoultchi, A. I. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600834 · Cited by 154 · cited 2×
“For example, during the differentiation of myeloid and erythroid lineages from common progenitors, PU.1 recruits SUV39H1, HP1 and the retinoblastoma (Rb) proteins and binds to GATA-1 on its target genes, thereby inhibiting erythroid differentiation (Stopka et al., 2005).”
BackgroundThe human β‐globin locus control region: A center of attraction
Levings, P. P., & Bungert, J. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2002.02797.x · Cited by 144 · cited 1×
“The b-globin locus is located on chromosome 11 and consists of five genes e, Gg, Ag, d and b which are under the regulation of a locus control region, located 6–22 kb upstream of the e-globin gene (Levings and Bungert, 2002).”
BackgroundSuzuki, M., Yamada, T., Kihara-Negishi, F., Sakurai, T., & Oikawa, T. (2003) · Oncogene · doi:10.1038/sj.onc.1207182 · Cited by 87 · cited 1×
“For example, MeCP2 has been shown to exist in a complex with the transcriptional co-repressor Sin3A and HDACs (Nan et al., 1998), and repressed the ability of PU.1 to activate transcription through its cognatebinding site (Bird, 2002; Suzuki et al., 2003).”
BackgroundMolecular pathogenesis of acute promyelocytic leukaemia and APL variants
Sirulnik, A., Melnick, A., Zelent, A., & Licht, J. D. (2003) · Best Practice & Research Clinical Haematology · doi:10.1016/s1521-6926(03)00062-8 · Cited by 54 · cited 1×
“APL is characterized by the accumulation of hematopoietic progenitors blocked at the promyelocyte stage of differentiation and is associated with chromosomal translocations that fuse either PML, PLZF, NuMA, NPM or STAT5b with the DNA ligand-binding domain of the RARa (Sirulnik et al., 2003).”
BackgroundSelf-citation
Cited by
ATP-citrate lyase links cellular metabolism to histone acetylation
Wellen, K. E., Hatzivassiliou, G., Sachdeva, U. M., Bui, T. V., Cross, J. R., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1164097 · Cited by 2,298
Aberrant DNA methylation is a dominant mechanism in MDS progression to AML
Jiang, Y., Dunbar, A., Gondek, L. P., Mohan, S., Rataul, M., O'Keefe, C., Sekeres, M., Saunthararajah, Y., & Maciejewski, J. P. (2009) · Blood · doi:10.1182/blood-2008-06-163246 · Cited by 384
Sprüssel, A., Schulte, J. H., Weber, S., Necke, M., Händschke, K., Thor, T., Pajtler, K. W., Schramm, A., König, K., Diehl, L., et al. (2012) · Leukemia · doi:10.1038/leu.2012.157 · Cited by 203
Chung, Y. S., Kim, H. J., Kim, T.-M., Hong, S.-H., Kwon, K.-R., An, S., Park, J.-H., Lee, S., & Oh, I.-H. (2009) · Blood · doi:10.1182/blood-2009-01-197780 · Cited by 43
Retinoid Differentiation Therapy for Common Types of Acute Myeloid Leukemia
Brown, G., & Hughes, P. (2012) · Leukemia Research and Treatment · doi:10.1155/2012/939021 · Cited by 39
Metadata
- Authors
- Rice, K. L., Hormaeche, I., & Licht, J. D.
- Venue
- Oncogene
- Published
- 2007-10-15
- Volume
- 26
- Issue
- 47
- Pages
- 6697-6714
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2051933106
- Cited by
- 158
- References
- 23
- FWCI
- 4.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.